After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A commonly prescribed pain medication—gabapentin—often considered a safer alternative to opioids for those who suffer from low back pain is now under scrutiny after being linked to increased risks of ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Researchers at the Lawson Health Research Institute, part of St. Joseph’s Health Care London, are studying Ambroxol, a cough ...

The annual review of clinical trials for Alzheimer’s highlights a growing number of active trials and drugs that could help ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

As Alzheimer's disease progresses, behavioral and psychiatric issues become common, distressing, and even dangerous for ...

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

China's top health authority has banned the use of a minimally invasive surgical procedure to treat Alzheimer's disease. The ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope. “Alzheimer’s disease is a specific condition resulting from an abnormal biological ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...